LCN2 and myeloid sarcoma: In the CNS, LCN2 is closely associated with altered brain homeostasis and specific regions affected in neurodegenerative diseases, including AD and MS, such as elevated levels of LCN2 in plasma and cerebrospinal fluid (CSF) in patients with mild cognitive impairment [125], depression [126], and MS [127].